- Home
- ZURA vs ITIC Comparison
ZURA vs ITIC Comparison
Compare ZURA & ITIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZURA | ITIC |
|---|---|---|
| Founded | 2022 | 1972 |
| Country | United States | United States |
| Employees | 30 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 521.8M | 431.1M |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | ZURA | ITIC |
|---|---|---|
| Price | $5.60 | $229.60 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $13.00 | N/A |
| AVG Volume (30 Days) | ★ 577.2K | 13.9K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 4.51% |
| EPS Growth | N/A | ★ 13.02 |
| EPS | N/A | ★ 18.57 |
| Revenue | N/A | ★ $272,755,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.59 |
| Revenue Growth | N/A | ★ 5.60 |
| 52 Week Low | $0.99 | $190.20 |
| 52 Week High | $7.25 | $288.98 |
Technical Indicators
Market Signals| Indicator | ZURA | ITIC |
|---|---|---|
| Relative Strength Index (RSI) | 41.93 | 56.09 |
| Support Level | $5.35 | $209.72 |
| Resistance Level | $5.75 | $234.49 |
| Average True Range (ATR) | 0.41 | 6.06 |
| MACD | -0.03 | 2.86 |
| Stochastic Oscillator | 29.51 | 79.54 |
Price Performance
Historical ComparisonAbout ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
About ITIC Investors Title Company
Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.